Moreover, compounds like carbenoxolone may also inhibit the Hippo pathway, indicating that a dual role depending on their context of use, targeting upstream regulators such as MST1/2 kinases, has emerged as a promising strategy to restore Hippo signaling and promote tumor suppression [129]. The gene discussed is MST1; the disease is neoplasm.